Hansen floats on NASDAQ:
This article was originally published in Clinica
Hansen Medical last week floated 6.25 million shares in an initial public offering at $12 per share on the US NASDAQ stock exchange. The Mountain View, California company develops products that use robotics to manipulate, control and position catheters. Its two lead products, the Sensei robotic catheter system and disposable Artisan control catheter, are pending FDA clearance.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.